The merger of Fem Care Pharma Ltd. with Dabur India Ltd has been approved by the Delhi and Bombay High Court. The shares of Dabur India Ltd. were allotted to Fem Care Pharma shareholders in the ratio of 5:1. The consolidated sales of Dabur India Ltd. in 2009-10 have registered a 20.6 percent growth over the previous fiscal to Rs 3,416.67 crore as against Rs 2,834.11 crore a year ago.